Advertisement
News
Subscribe to MDT Magazine News

MAQUET Cardiovascular Receives 510(k) Clearance to Market the CARDIOHELP System in U.S.

April 28, 2011 6:35 am | by Bio-Medicine.Org | Comments

WAYNE, N.J., April 28, 2011 /- MAQUET Cardiovascular today announced that the U.S. Food and Drug Administration has granted the company 510(k) clearance to market its CARDIOHELP System in the United States as a cardiac and/or respiratory assist device for up to six hours.  The...

TOPICS:

Onda Reaches Distribution Agreement with S & V Korea to Expand Presence in South Korea

April 28, 2011 6:34 am | by Bio-Medicine.Org | Comments

SUNNYVALE, Calif., April 28, 2011 /- Onda Corporation, the leading global provider of ultrasound measurement instrumentation, announced an agreement with S&V Korea for distribution of its products to the government and academic sector in South Korea. S&V Korea is a leading...

TOPICS:

Public Workshop - Study Methodologies for Diagnostics in the Postmarket Setting, May 12, 2011

April 28, 2011 6:30 am | by U.S. Food & Drug Administration | Comments

The purpose of the workshop is to provide a forum for discussion among FDA, governmental agencies, academia, physicians and various stakeholders with expertise in epidemiology, statistics, diagnostics and biomedical research to advance the methodologies f

TOPICS:
Advertisement

BIOLASE to Present at MDB Capital's Bright Lights Conference in New York City

April 28, 2011 5:45 am | by The Associated Press | Comments

BIOLASE Technology, Inc. (NASDAQ: BLTI), the World's leading dental laser manufacturer and distributor, today announced that management is scheduled to make an investor presentation at MDB Capital's 2nd Annual Bright Lights Conference on Tuesday, May 10, at 9:30 am Eastern Time. The...

PositiveID Corporation's iglucose Mobile Health Solution for Diabetes Management to be Featured at American Telemedicine Association Annual International Meeting & Exhibition ...

April 28, 2011 5:32 am | by PositiveID | Comments

PositiveID Corporation's iglucose Mobile Health Solution for Diabetes Management to be Featured at American Telemedicine Association Annual International Meeting & Exhibition 2011

TOPICS:

Medco Health Solutions 1Q profit rises 4 percent

April 28, 2011 3:45 am | by The Associated Press | Comments

Pharmacy benefits manager Medco Health Solutions Inc. said Thursday its profit rose 4 percent in the first quarter on an increase in the volume of mail-order generic drug prescriptions and retail prescriptions.The Franklin Lakes, N.J., company said its profit rose to $333.1 million, or 80 cents...

STAAR Surgical's nanoFLEX™ Collamer® IOL Receives CE Mark Approval

April 28, 2011 3:36 am | by Bio-Medicine.Org | Comments

MONROVIA, Calif., April 28, 2011 /- STAAR Surgical Company (NASDAQ: STAA ), a leading developer, manufacturer and marketer of minimally invasive ophthalmic products, today announced CE Mark approval for its nanoFLEX™ Collamer® Single Piece IOL which can be injected through a...

TOPICS:

Reportlinker Adds Pharmaceutical Key Trends 2011 - Prescription Pharmaceutical Sales Overview

April 28, 2011 3:36 am | by Bio-Medicine.Org | Comments

NEW YORK, April 28, 2011 /- Reportlinker.com announces that a new market research report is available in its catalogue: Pharmaceutical Key Trends 2011 - Prescription Pharmaceutical Sales Overview...

TOPICS:
Advertisement

AMETEK ACQUIRES AVICENNA TECHNOLOGY

April 28, 2011 3:34 am | by Bio-Medicine.Org | Comments

BERWYN, Pa., April 28, 2011 /- AMETEK, Inc. (NYSE: AME ) today announced that it has acquired Avicenna Technology, Inc., a privately held supplier of custom, fine-featured components used in the medical device industry.  Avicenna Technology with its headquarters and manufacturing...

TOPICS:

Aetna's 1Q profit rises 4 pct, revenue falls

April 28, 2011 2:45 am | by The Associated Press | Comments

Aetna says its first-quarter profit rose 4 percent as claims left over from the previous quarter came in lower than the health insurer expected. But it says revenue and enrollment dropped.The insurer also says it has agreed to buy Prodigy Health Group, a large administrator of self-funded...

International Leaders in Electrophysiology Discuss Improving Atrial Fibrillation Treatment Using Novel Endoscopically Guided Laser Ablation Catheter

April 28, 2011 2:33 am | by Bio-Medicine.Org | Comments

MARLBOROUGH, Mass., April 28, 2011 /- CardioFocus, Inc., developer of the Endoscopic Ablation System for the transcatheter treatment of Atrial Fibrillation (AF), convened international leaders in electrophysiology to discuss the advantages of direct optical visualization to guide catheter...

TOPICS:

Rhythmia Medical Highlights Studies to be Presented at Heart Rhythm Society 2011 Annual Scientific Session

April 28, 2011 12:33 am | by Bio-Medicine.Org | Comments

BURLINGTON, Mass., April 28, 2011 /- Rhythmia Medical Inc., announced today that key results from its ongoing pre-clinical and clinical studies will be presented at the 2011 Annual Scientific Session of the Heart Rhythm Society in San Francisco, CA. The results will highlight the...

TOPICS:

Catching signs of autism early: The 1-year well-baby check-up approach

April 27, 2011 10:33 pm | by EurekAlert | Comments

(University of California - San Diego) A novel strategy developed by autism researchers at the University of California, San Diego School of Medicine, called "The One-Year Well-Baby Check Up Approach," shows promise as a simple way for physicians to detect cases of autism syndrome...

TOPICS:

5-minute screen identifies subtle signs of autism in 1-year olds

April 27, 2011 10:32 pm | by EurekAlert | Comments

(NIH/National Institute of Mental Health) A five-minute checklist that parents can fill out in pediatrician waiting rooms may someday help in the early diagnosis of autism spectrum disorder (ASD), according to a study funded by the National Institutes of Health. Published today in the...

TOPICS:

Priming the Body to Tackle Cancer

April 27, 2011 8:36 pm | by Massachusetts Institute of Technology | Comments

Immune therapy proves effective against melanoma in an early trial.

TOPICS:

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading